GNPX
Genprex IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.69M
P/E Ratio
—
EPS
$-5.06
Beta
-0.93
52W High
$55.00
52W Low
$0.74
50-Day MA
$1.27
200-Day MA
$4.84
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Genprex Inc
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-15.51M |
| Operating Margin | 0.00% |
| Return on Equity | -160.80% |
| Return on Assets | -76.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.42 |
| Price-to-Book | 0.51 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.18 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $10.59M |
| Float | $10.56M |
| % Insiders | 0.97% |
| % Institutions | 1.01% |
Historical Volatility
HV 10-Day
38.88%
HV 20-Day
70.25%
HV 30-Day
74.29%
HV 60-Day
69.17%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/25/2026